Following publication, the authors reported errors in Table 1 . These included an incorrect F-value and p-value for the middle frontal gyrus cluster significant in the MID whole-brain drug Page 1052, 'MID fMRI', second paragraph under 'Effects of group and drug: whole-brain analysis', the figure displaying the drug effect within the middle frontal gyrus is Supplementary Figure S5 , not S3 as stated.
Page 1052, 'MID fMRI', second paragraph under 'ROI analysis', for the substantia nigra region of interest, the F-value for the exploratory main effect of group comparison using the placebo data should be 4.01, not 5.03. However, the stated associated p-value of 0.022 is correct. (Note that the F-value of 5.03 given earlier in the paragraph for the ventral striatum comparison is correct).
Page 1052, 'GNG fMRI-Effect of Task', under 'ROI analysis', the statistics for the main effect of group within the right inferior frontal gyrus (IFG) should be '(F(2,70) = 4.45, p = 0.015)', not '(F(2,) = 4.71, p = 0.012)'. The p-value for the trend effect within the left IFG should be 0.036, not 0.024. The errors in these GNG ROI statistics appear only on this page; they were presented correctly in the original Table 1 .
Page 1055, last paragraph above 'GNG', 'GSK898809' should be 'GSK598809'.
These errors do not alter the conclusions of the report. The authors apologize for any inconvenience.
